Precision Oncology and Regenerative Strategies in Esophageal Cancer: From Tumor Cell Plasticity and Microenvironmental Networks to Functional Models and Tissue Repair
Esophageal cancer (EC), comprising esophageal squamous cell carcinoma and esophageal adenocarcinoma, remains a highly aggressive malignancy characterized by substantial intratumoral heterogeneity, cellular plasticity, therapeutic resistance, and poor clinical outcomes. Increasing evidence indicates that EC progression is governed not only by tumor-intrinsic genetic alterations but also by dynamic interactions among signaling networks, metabolic and epigenetic programs, cancer stem-like states, stromal and immune cells, extracellular matrix, vasculature, neural components, and the microbiome. In this review, we synthesize advances in the cellular and molecular biology of EC and discuss their implications for precision therapeutic strategies, with emphasis on oncogenic signaling, pathway rewiring, tumor–microenvironment interactions, cancer stem-cell plasticity, and emerging biomarker platforms, including multi-omics, liquid biopsy, extracellular vesicles, single-cell sequencing, and spatial transcriptomics. We further examine patient-derived organoids, organoid–immune co-culture systems, three-dimensional bioprinted tumor models, and computational approaches as functional platforms for investigating tumor heterogeneity, therapeutic response, and treatment resistance. Beyond tumor control, tissue-engineering and regenerative strategies for repairing treatment-associated mucosal injury, fibrosis, stricture, and tissue loss are discussed. Importantly, regenerative interventions require careful oncologic consideration because pathways involved in tissue repair, stem-cell activation, angiogenesis, and extracellular-matrix remodeling may influence residual malignant cells. Finally, we highlight the convergence of precision oncology, functional tumor modeling, regenerative medicine, and artificial intelligence, while addressing challenges in standardization, validation, scalability, regulation, and clinical translation.
Authors
- Stefano Cacciatore (ORCID: https://orcid.org/0000-0001-7052-7156)
- Ali Merito Ali
- Ibrahim Houmed Aboubaker
- Fatouma Mohamed Abdoul‐Latif (ORCID: https://orcid.org/0000-0001-7213-4700)
- Saredo Mohamed Hassan
- Rohit Kumar
Publication Details
- Journal
- Preprints.org
- Published
- 2026-11-12
- DOI
- https://doi.org/10.20944/preprints202611.1338.v1
- Primary Topic
- Esophageal Cancer Research and Treatment
- Type
- preprint